genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
OXGENE Eyes Further Growth in Cell and Gene Therapy Services after…
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
News
Cancer
Immunotherapy Boost May Come from Dendritic Cell Factories
News
New Insights into Ancient Gatekeeper Protein Complex
Imaging analysis
Study of Human Brain Images Generates New Insights into the Neurobiology…
Drug Discovery
Researchers Engineer E. coli for Animal-Free Drug Manufacturing
OMICs
Microbial Cross-Feeding in Human Gut Predicted by Novel Computational Tool
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Preparing before Joining Biopharma’s Digital Gold Rush
Bioprocessing
Putting Pressure On Cells to Kill Cancer
Bioprocessing
Tips to Ensure Product Comparability in Gene Therapy
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Immunotherapy Boost May Come from Dendritic Cell Factories
Gene Therapy
OXGENE Eyes Further Growth in Cell and Gene Therapy Services after…
Bioprocessing
Preparing before Joining Biopharma’s Digital Gold Rush
Bioprocessing
Putting Pressure On Cells to Kill Cancer
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Blood Disorders
Blood Disorders
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Blood Disorders
Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood Transplants
Blood Disorders
CRISPR Exploits Vulnerability of Sickle Cell Disease
Blood Disorders
Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’
Blood Disorders
Pfizer, Sangamo Report Positive Phase I/II Data for Severe Hemophilia A Gene Therapy
Blood Disorders
Inspiration Enters Chapter 11, Seeks Buyer
Blood Disorders
Celgene Pays Acceleron $25M to Add Second Candidate to Anemia Collaboration
Blood Disorders
CRISPR Editing of Stem Cell Subset Reactivates Fetal Hemoglobin for Treating...
Blood Disorders
Sanofi Snaps Up Bioverativ for $11.6B, Boosting Hemophilia and Rare Disease...
Blood Disorders
Sandoz’ Biosimilar to Amgen’s Anemia Drug Gets EU Go-Ahead
Blood Disorders
Sickle Cells Can Cut Off Tumors’ Lifeline
Blood Disorders
Novartis to Develop Treatments for Eye, Blood Disorders Using Homology’s AAV...
Blood Disorders
Novo Nordisk Reports Promising Phase III Results for Hemophilia Candidate
Blood Disorders
Gene Therapy Shows Promise for Treating Beta-Thalassemia and Sickle Cell Disease
Blood Disorders
After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial...
Blood Disorders
Xenon Pays Isis $2M for Exclusive License to Co-Developed Antisense Drug
1
2
3
...
14
Page 1 of 14
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
